Aptamer Drug Conjugates (ApDC)
Aptamers are readily modified during their solid phase synthesis. This enables facile conjugation of a variety of therapeutic modalities, including therapeutic agents, other nucleic acids (e.g. siRNA), nanoparticles, proteins etc. These conjugates are then effectively delivered to the site of action, by the aptamer.